Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 4, 2014, Pages 105-115

  Mouradian, M ^a   Kikawa, K D ^a   Johnson, E D ^a   Beck, K L ^a   Pardini, R S ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

Breast cancer; EGFR; Gab1; Linoleic acid; Lung cancer; PI3K

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GRB2 ASSOCIATED BINDING PROTEIN 1; LINOLEIC ACID; MATRIX METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; SCAFFOLD PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; GAB1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BLOOD; BREAST TUMOR; CANCER TRANSPLANTATION; CARCINOGENESIS; DRUG EFFECTS; FEMALE; LUNG TUMOR; METABOLISM; NUDE MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

MURINAE; MUS; MUS MUSCULUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; HUMANS; LINOLEIC ACID; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHATIDYLINOSITOL 3-KINASES; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84896399543     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.12.001     Document Type: Article

References (47)

1. Pardini R.S. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem. Biol. Interact. 2006, 162:89-105.
2. Chapkin R.S., Seo J., McMurray D.N., Lupton J.R. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids 2008, 153:14-23.
3. Bang H.O., Dyeberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med. Scand. 1976, 200:69-73.
4. Dunn J.E. Cancer epidemiology in populations of the United States-with emphasis on Hawaii and California-and Japan. Cancer Res. 1975, 35:3240-3245.
5. Willett W.C. Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am. J. Clin. Nutr. 1997, 66:1557S-15563S.
6. Welsch C.W. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res. 1992, 52:2040S-2048S.
7. Rose D.P. Dietary fat, fatty acids and breast cancer. Breast Cancer 1997, 4:7-16.
8. Hudson E.A., Beck S.A., Tisdale M.J. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem. Pharmacol. 1993, 45:2189-2194.
9. Connolly J.M., Coleman M., Rose D.P. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr. Cancer 1997, 29:114-119.
10. Hillyard L.A., Abraham S. Effect of dietary polyunsaturated fatty acids on growth of mammary adenocarcinomas in mice and rats. Cancer Res. 1979, 34:4430-4437.
11. Carter C.A., Millholland R.J., Shea W., Ip M.M. Effect of the prostaglandin synthesis inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 1983, 43:3559-3562.
12. Abou-El-Ela S.H., Prasse K.W., Carroll R., Wade A.E., Dharwadkar S., Bruce O.R. Eicosanoid syntheses in 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil. Lipids 1988, 23:948-954.
13. Kitigawa H., Noguchi M. Comparative effects of piroxicam and esculetin on incidence, proliferation and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz(a)anthracene on rats on high and low fat diets. Oncology 1995, 51:407-410.
14. Wymann M.P., Schneiter R. Lipid signaling in disease. Nat. Rev. Mol. Cell Biol. 2008, 9:162-176.
15. Noguchi M., Rose D.P., Earashi M., Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitor in breast carcinoma. Oncology 1995, 52:265-271.
16. Schrey M.P., Patel K.V. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br. J. Cancer 1995, 72:1412-1419.
17. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 2002, 8:289-293.
18. Kikawa K.D., Herrick J.S., Tateo R.E., Mouradian M., Tay J.S., Pardini R.S. Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line is enhanced by supplementation with docosahexaenoic acid. Nutr. Cancer 2010, 62:1017-1024.
19. Rogers K.R., Kikawa K.D., Mouradian M., Hernandez K., McKinnon K.M., Ahwah S.M., Pardini R.S. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 2010, 31:1523-1530.
20. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
21. de Kok J.B., Roelofs R.W., Giesendorf B.A., Pennings J.L., Waas E.T., Feuth T., Swinkels D.W., Span P.N. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest. 2005, 85:154-159.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Connolly J.M., Liu X.H., Rose D.P. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr. Cancer 1997, 29:48-54.
24. Lee S.A., Kim H.J., Chang K.C., Baek J.C., Park J.K., Shin J.K., Choi W.J., Lee J.H., Paik W.Y. DHA and EPA down-regulate COX-2 expression through suppression of NF-kappaB activity in LPS-treated human umbilical vein endothelial cells. Korean J. Physiol. Pharmacol. 2009, 13:301-307.
25. Legler D.F., Bruckner M., Uetz-von Allmen E., Krause P. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int. J. Biochem. Cell Biol. 2010, 42:198-201.
26. Espinosa-Neira R., Mejia-Rangel J., Cortes-Reynosa P., Salazar E.P. Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A. Int. J. Biochem. Cell Biol. 2011, 43:1782-1791.
27. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling development and disease. J. Cell Biol. 2006, 172:973-981.
28. Mattoon D.R., Lamonthe B., Lax I., Schlessinger J. The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway. BMC Biol. 2004, 18:12-24.
29. Engelman J.A. Targeting PI3K signaling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 2009, 9:550-562.
30. Sithanadam G., Smith G.T., Fields J.R., Fornwald L.W., Anderson L.M. Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1. Am. J. Respir. Cell Mol. Biol. 2005, 33:390-399.
31. Yart A., Mayeux P., Raynal P. Gab1, SHP-2 and other novel regulators of Ras: target for anticancer drug discovery?. Curr. Cancer Drug Targets 2003, 3:177-192.
32. Scheaper U., Vogel R., Chmielowiec J., Huelsken J., Rosario M., Birchmeier W. Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. Proc. Natl. Acad. Sci. 2007, 104:15376-15381.
33. Chen S.Y., Chen H.C. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote growth factor-induced cell invasion. Mol. Cell. Biol. 2006, 26:5155-5167.
34. Rose D.P., Connolly J.M. Influence of dietary linoleic acid on experimental human breast cancer cell metastasis in athymic nude mice. Int. J. Oncol. 1998, 13:1179-1183.
35. Matsuoka T., Adair J.E., Lih F.B., His L.C., Rubino M., Eling T.E., Tomer K.B., Yashiro M., Hirakawa K., Olden K., Roberts J.D. Elevated dietary linoleic acid increase gastric carcinoma cell invasion and metastasis in mice. Br. J. Cancer 2010, 103:1182-1191.
36. Goormachtigh G., Ji Z., Le Goff A., Fafeur V. Degradation of the Gab1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-Met signaling. Biochem. Biophys. Res. Commun. 2011, 411:780-785.
37. Ciardiello F., Kim N., McGeadyL M.L., Liscia D.S., Saeki T., Bianco C., Salomon D.S. Expression of transforming growth factor alpha (TGF alpha) in breast cancer. Ann. Oncol. 1991, 2:169-182.
38. Lin C.Q., Dempsey P.J., Coffey R.J., Bissel M.J. Extracellular matrix regulates whey acidic protein gene expression by suppression of TGF-alpha in mouse mammary epithelial cells: studies in culture and in transgenic mice. J. Cell Biol. 1995, 129:1115-1126.
39. Suzuki I., Iigo M., Ishikawa C., Kuhara T., Asamoto M., Kunimoto T., Moore M.A., Yazawa K., Araki E., Tsuda H. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int. J. Cancer 1997, 73:607-612.
40. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H., Fuji Y., Eck M.J., Sellers W.R., Johnson B.E., Meyerson M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
41. Yan L., Beckman R.A. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Biotechniques 2005, 39. (565-368).
42. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.
43. Harbige L.S. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003, 38:323-341.
44. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 2008, 233:674-688.
45. Johnson G.H., Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J. Acad. Nutr. Diet 2012, 112. (1029-41, 1041.e1-15).
46. Fritsche K.L. Too much linoleic acid promotes inflammation-doesn't it?. Prostaglandins Leukot Essent. Fatty Acids 2008, 79:173-175.
47. Folch J., Lees M., Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.